Triple
T15982954
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Ariad Pharmaceuticals |
E387618
|
entity |
| Predicate | regulatoryBodyInteraction |
P79837
|
FINISHED |
| Object | U.S. Food and Drug Administration |
E13297
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: U.S. Food and Drug Administration | Statement: [Ariad Pharmaceuticals, regulatoryBodyInteraction, U.S. Food and Drug Administration]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Context triple: [Ariad Pharmaceuticals, regulatoryBodyInteraction, U.S. Food and Drug Administration]
-
A.
Food and Drug Administration
chosen
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
B.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
E.
FDA CFSAN
FDA CFSAN is the U.S. Food and Drug Administration’s center responsible for regulating the safety, labeling, and nutritional quality of foods, dietary supplements, and cosmetics.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: regulatoryBodyInteraction Context triple: [Ariad Pharmaceuticals, regulatoryBodyInteraction, U.S. Food and Drug Administration]
-
A.
regulatoryEngagement
chosen
Indicates a relationship where one party interacts with or responds to regulatory bodies or frameworks, typically through compliance activities, consultations, filings, or other formal communications.
-
B.
hasRegulatoryOrCulturalBody
Indicates that an entity is overseen, guided, or influenced by a formal regulatory authority or a culturally significant governing body.
-
C.
associatedWithRegulation
Indicates a relationship where something is linked to, governed by, or relevant to a specific regulation or regulatory framework.
-
D.
governingBodyInvolvement
Indicates the extent or manner in which a governing body participates in, oversees, or influences a particular activity, decision, or entity.
-
E.
regulationImpact
Indicates how a regulation influences, constrains, or alters the behavior, performance, or outcomes associated with the related entities.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d86da94ccc819083d187f5dc6a123e |
completed | April 10, 2026, 3:25 a.m. |
| NER | Named-entity recognition | batch_69e17d4d08f481909f38b75e3f42d9ab |
completed | April 17, 2026, 12:22 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69ffcf1abad48190a42510605c30d0b3 |
completed | May 10, 2026, 12:19 a.m. |
| PD | Predicate disambiguation | batch_69e142d9d8e881909b559a3e3ca21d24 |
completed | April 16, 2026, 8:13 p.m. |
Created at: April 10, 2026, 4:54 a.m.